Sumitomo Pharma America is closed on July 4 and July 5 for Independence Day. Celebrate safely with your friends and family. Happy birthday, America! #IndependenceDay #4thofJuly #Sumitomolife
Sumitomo Pharma America, Inc.’s Post
More Relevant Posts
-
CEO & President Prathista international-USA, promotes plant based,natural, clean label fermented floor solutions as active food/feed ingredients.Increase shelf life and reduce food wastage globally with antimicrobials
News up dates :- Acquisitions and M&As became regular practice since COVID period particularly Prathista Industries Limited is in consolidation status Main focus of Prathista Industries Limited is now on global business with natural products including organic agri inputs as per NPOP / NOP standards for total crop management practices. Few aquisations / M&A activities from #prathista is also in process for one USA based company and few Chinese companies are on cards to acquire them to be global player and due diligence activities are in process as per global standards. #prathista is being “Confined” to our core strengths of Organic agriculture / clean label solutions, natural and plant (vegan) based food / feed ingredients and livestock segment products being produced using non GMO through fermentation processes. Tripura Bio Tech Limited was focusing on organic fertilisers and home / kitchen garden products since 1998 & sold out other Pharma / food ingredients products to #prathista since 2019 and the deal is limited to marketing rights only of agricultural products. Globally known MNC acquired Tripura Biotech Limited after 3 years of due diligence during April 2023 to enter into Indian market as #Tripura have all required licenses and range of bio Stimulants/FCO act fertilisers which is huge value addition for MNC who brought the company. #globalbusiness #aquisitions #mergersandacquisitions #fermentation #process #corestrength #focusgroup #organicagriculture #cleanlabel #solutions #plantbased #naturalingredients #nongmo #privateequity #venturecapitalists
Updated information about Tripura Biotech Limited has been sold to an Multi National Company and is being handled by new management…. All the best for the new team members on this journey
To view or add a comment, sign in
-
🎆 Did you know that a pioneer of pharma was born on the 4th of July? 🎆👇🏻 Edward Robinson Squibb, born on July 4, 1819, was a visionary chemist and pharmaceutical manufacturer whose innovations have had a lasting impact on the biotech and pharmaceutical industries. During his time as a U.S. Navy medical officer, Squibb pushed for the Navy to manufacture its own drugs to ensure better quality. In 1851, he set up a laboratory at the Brooklyn Naval Hospital, where he developed safer methods for producing ether, a crucial anesthetic, using a steam coil still instead of an open flame. Squibb’s dedication to transparency and quality was evident as he chose to publish his discoveries rather than patent them, promoting shared scientific progress. By 1858, he had established his own business, offering a wide range of pharmaceutical products, laying the foundation for modern pharmaceutical practices. This 4th of July, we not only celebrate our nation’s independence but also honor the relentless spirit of innovation exemplified by pioneers like Squibb. Their contributions ensure we enjoy the freedom to lead healthier lives. 🇺🇸 #FourthofJuly #IndependenceDay #BiotechInnovation #PharmaceuticalPioneer #HealthcareHeroes #ScientificProgress #MedicalAdvancements #QualityMedicine #EdwardSquibb #ChemistryChampion #InnovativeScience #HealthcareRevolution #ScienceHistory #BiotechBreakthroughs #PharmaIndustry #MedicalPioneers #AmericanHeroes #ScientificDiscovery #MedicalResearch #HealthInnovation #PioneersOfScience #CelebratingScience #HistoricalFigures #ChemistryLegacy #ModernMedicine #ScienceAndInnovation #PatrioticPioneers #FreedomAndInnovation #NationalPride #HealthcareLegends #IndependenceAndInnovation Bristol Myers Squibb
To view or add a comment, sign in
-
-
Many thanks to Ben Wu for his talk on Biopharma in China at China Crossroads.
To view or add a comment, sign in
-
-
Always Leading with Technology!!
𝗘𝘅𝗰𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝗶𝗱𝗲𝗮𝘀, 𝗼𝗽𝗶𝗻𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝘃𝗶𝘀𝗶𝗼𝗻𝘀 𝗮𝘁 𝗔𝗖𝗛𝗘𝗠𝗔 𝟮𝟬𝟮𝟰 🌍 Greetings on the opening day of this exciting event! ACHEMA 2024 is the go-to trade fair for chemical, pharmaceutical, and biotech manufacturers, and our teams from ProLeiT and Schneider Electric are pumped to be right here in Frankfurt for this special occasion. We're really excited to have our Global Head of Sales, Fred Vanhove, joining us to share some valuable perspectives. This event is all about the latest trends in the chemical industry, with a big focus on the need for reliable software solutions. And that's something we're known for at ProLeiT. Want to know more about these solutions? Fred's got the scoop in our first event video this week. Feeling curious and up for a chat? No problem! We're here for you until the 14th of June at Hall 11.1 Booth C86. Your support means a lot to us! #ProLeiT #ACHEMA2024 #AutomationSolutions #chemical #industry #PlantiT
Exchanging ideas, opinions and visions at ACHEMA 2024
To view or add a comment, sign in
-
Quascenta (QMS & PQMS including eLogbook, eResidue Pro, eProcess Pro, ValDoc Pro) & Alconox (Cleaning Detergent, Cleaning Validation)
I attended the <BIO KOREA 2024> event held at Coex Exhibition Center in Seoul. While the number of attendees hasn't fully recovered to pre-COVID-19 pandemic levels, qualitatively, it was impressive to see the participation of top-notch companies and partners from around the globe. I had pleasant conversations with various #CDMO companies from the United States, Europe, and Asia. Of course, I also exchanged warm greetings with Korean companies. I extend my gratitude to everyone who kindly exchanged business cards with warm greetings. Customers showed a high interest in Quascenta Pte. Ltd.'s offerings like eLogbook, eProcess Pro, and eResidue Pro, which aim to enhance the quality of processes. I believe this warm interest stems from the admirable sense of purpose among CDMO companies striving to deliver better quality to their customers. Personally, rather than solely aiming for sales achievements, I too aspire to take a deeper interest in Quascenta's mission to contribute to the pharmaceutical industry. I respect Ravi Moorthy, the leader of Quascenta, because he believes in integrating our software, knowledge, and experience to deliver more value to customers. #전자로그북 #eLogbook #DataIntegrity #PharmaDigitalization #We_Consider #Quality #Quascenta
To view or add a comment, sign in
-
-
Meet two more #veteranentrepreneurs and innovators from the 2023 Veteran Shark Tank. Branson Berger and Sean Finney of Tano Pharmaceuticals are using banana sap to revolutionize skin and wound care. Connect with them and learn more about their work. #veteransharktank #veterans
To view or add a comment, sign in
-
-
The market of mycotoxin product is completely overloaded with different mixtures claiming more or less everything. In 2023 we still saw companies in the EU claiming DON and T2 adsorption which is scientifically proven to be not feasible. Stay with the facts, show scientific proof and go for EU-registration. This is the research I want to show to my customers that they understand that they buy the best product on the market. No fluffy promises, sound data! In-vitro, In-vivo and biomarker! ZENzyme is besides BBSH 797 and FUMzyme the next innovation in our #MycotoxinRiskManagment!
Technical Marketing Manager Swine - Animal Nutrition and Health D + CH - dsm-firmenich Nutritional Products
A poster on the new invention of dsm-firmenich. ZENzyme. We hope to get it registered in Europe in the near future. Until then we rely on the success that we had and have with the Mycofix versions available all over Europe. Still the only EFSA approved products against many mycotoxines.
To view or add a comment, sign in
-
-
https://lnkd.in/dJeZ2KVk Breaking Ground in Pharma Supply Chain: Check out our latest article on The Wolf Practice website, diving deep into the game-changing strategies for tackling serialization challenges! 🚀 💼 #PharmaInnovation #SupplyChainSolutions #TheWolfPractice
To view or add a comment, sign in
-
-
Entrepreneur & Active Investor in People and Megatrends, MK Family-Office, Host MK Investment Conference Munich, Optimtrader, Corporate Builder as Public Equity & Angel Investor
If #CapitalMarkets would react rational then the newsrelease below would have a major impact on the strong growing #Biopharma #Company called Avicanna Inc. (TSX:AVCN). Well I suppose in a world where the investment $$ are allocated only to the top US megabrands like Apple Alphabet Inc. Tesla & Co or alternativly to #ETFs, the smart money is scare and might need a day or too to react. Sooner than later - this news must see a reacton in the market of Avicanna Inc. (TSX:AVCN), as this is a true milestone achieved from Aras Azadian and Phillip Cardella, CPA, CA cutting a partnership with a multinational #European #Pharma #corporation. Avicanna is doing things differently than othes. It is a fully vertically integrated biopharma company with several diversified and complementary business lines. The company is run by its management target oriented and growth driven and is active in multiple international countries. It is backed by strategic and smart money investors which receive quarterly reports that are state of the art. We presented our portfolio company in 2022 to our audience of professional investors and we hope to see themagain this year in Munich on Oct 2nd. Check out the news release below - this stock will move - mark my words. https://lnkd.in/d_mgyk28
To view or add a comment, sign in